A multi-center phase II trial of capecitabine in combination with oxaliplatin (Xelox) as first line chemotherapy in patients with metastatic nasopharyngeal carcinoma
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Capecitabine; Oxaliplatin
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- 20 Sep 2006 New trial record.